Phase III randomized, doubleâblind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinumâcontaining regimen ( RADPAC )
Lorenzen, Sylvie, Knorrenschild, Jorge Riera, Pauligk, Claudia, HegewischâBecker, Susanna, Seraphin, Jörg, ThussâPatience, Peter, Kopp, HansâGeorg, Dechow, Tobias, Vogel, Arndt, Luley, Kim BarbJournal:
International Journal of Cancer
DOI:
10.1002/ijc.33025
Date:
May, 2020
File:
PDF, 1.81 MB
2020
File converter
More search results
More benefits 
